Heos

Simplifying

Highlights

Vulcano

Specs

Team

Application

Producing next-gen 3D bioprinters powered
by AI & Computer Vision

Heos Machine A1

Ai&Computer vision system

Heos Machine Vulcano

Modules

Our first commercial bioprinter with 1 micron accuracy. A1 was tested and purchased in 14 labs and companies across the globe

A modular structure enables cost-effective customization and flexibility

AI & Computer vision improves selection of parameters, error detection, and use of resources

Simplifying bioprinting

Vulcano is our new model that will be available in the next few months. It will simplify bioprinting while keeping the accuracy

Designed for your lab, see for yourself

Approved by dozens of biologists, physicists and chemists

positioning accuracy

1 µm

Our diverse experience in manufacturing CNC machines, nuclear equipment and biotech enabled us to obtain the necessary precision

dosing accuracy

5 nL

For a syringe extruder. Pneumatic and other extruders are on the track.

modules

12

We offer a wide range of modules to meet diverse customer needs

clients worldwide

10+

We serve customers across the world (North America, Europe and Asia)

Designed for your lab, see for yourself

Approved by dozens of biologists, physicists and chemists

positioning accuracy

1 µm

Our diverse experience in manufacturing CNC machines, nuclear equipment and biotech enabled us to obtain the necessary precision

dosing accuracy

5 nL

For a syringe extruder. Pneumatic and other extruders are on the track.

modules

12

We offer a wide range of modules to meet diverse customer needs

clients worldwide

10+

We serve customers across the world (North America, Europe and Asia)

Vulcano is coming, leave a request for test use

Cases

We are constantly looking for new labs to test our bioprinter

Integrations

We integrate solutions from various fields to make our devices ready for any test. Nuclear industry, biology, chemistry, pneumatics and physics

17 Patents

We are in the process of registering patents

Certification

We are committed to designing our bioprinters with the highest standards

x2 Faster

Print your objects easier, more reliably and faster

Cases

We are constantly looking for new labs to test our bioprinter

Integrations

We integrate solutions from various fields to make our devices ready for any test. Nuclear industry, biology, chemistry, pneumatics and physics

17 Patents

We are in the process of registering patents

Certification

We are committed to designing our bioprinters with the highest standards

x2 Faster

Print your objects easier, more reliably and faster

430x580x580

Outer dimensions (LxWxH) in mm

Technical specifications

18 kg

Weight

230x230x45

Build volume in mm

Multi-well plates, petri dishes, glass

Build surface compatibility

3

Slides Resolution XY in μm

1 Accuracy: XY 3 μm | Z 2 μm

Layer resolution in μm

1

No. of printhead slots

1 lamp

UV sterilization

Yes

Calibration

Open-source software

User interface

gcode

Supported file formats

Repetier-Host, Cura, Pronterface etc

Software - G-Code

220/110 V 250W

Power input

0.5 μl-5 ml

Syringe volume

±8 μm

Piston position accuracy

We assembled a breakthrough thinktank team of the best experts in bioprinting, cell engineering, pharma, biotech with 120+ years of combined experience in related fields

Maksim Jmihov

CEO

Built three successful and
profitable companies in B2B
segments. Past business clients: EPAM, Shell, H&M, P&G

Anthony DeBiase

14+ years in biotech. Manufacturing Director at 3DBio Therapeutics, the only clinical-stage company with custom-engineered 3D-bioprinted living implants

Gabor Forgacs

Gardner Butterworth

16+ years in bioprinting.
Co-founder of Organovo, first commercial 3D bioprinting company, and Modern Meadow (develops consumer animal products)

5+ years in executive sales positions in 3D bioprinting. Ex-Head of Sales at market leaders Allevi and BICO. Founder & CEO at clinical research company Trialist

Derek Mathers

Gusten Danielsson

9+ years in senior business development & consultant roles in healthcare. As BD Director at Ricoh USA, he leads its medical 3D printing department

7+ years in 3D bioprinting.
Co-Founder and Ex-CFO at BICO, the world’s leading bioconvergence company with 65+ countries in geo coverage and $200mn FY22 revenue

Harry Boeltz

Henrik Åkesson

23+ years in bioscience.
Co-Founder of Dispendix, single-cell printing biotechnology company (acquired in 2018 by BICO)

6+ years in executive positions in 3D printing. CBO at UpNano, Austrian 3D printing company, where he leads sales &distribution network and strategic positioning

Simon MacKenzie

CBDO

22+ years in executive roles in biotech. Ex-CEO at RegenHU, the Swiss 3D bioprinting pioneer, where he led the company’s refocusing and growth

Pre-order? More information?

Get in Touch!

hello@heos.bio

Pre-order? More information?

^{Get in Touch: hello@heos.bio}